发明申请
US20070179188A1 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
审中-公开
额外的杂多环化合物及其作为代谢型谷氨酸受体拮抗剂的用途
- 专利标题： Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
- 专利标题（中）： 额外的杂多环化合物及其作为代谢型谷氨酸受体拮抗剂的用途
-
申请号： US10588702申请日： 2005-02-15
-
公开(公告)号： US20070179188A1公开(公告)日： 2007-08-02
- 发明人: Louise Edwards , Methvin Isaac , Martin Johansson , Annika Kers , Johan Malmberg , Donald Mcleod , Alexander Minidis , Karin Staaf , Abdelmalik Slassi , Tomislav Stefanac , Thomas Stormann , David Wensbo , Tao Xin , Jalaj Arora
- 申请人： Louise Edwards , Methvin Isaac , Martin Johansson , Annika Kers , Johan Malmberg , Donald Mcleod , Alexander Minidis , Karin Staaf , Abdelmalik Slassi , Tomislav Stefanac , Thomas Stormann , David Wensbo , Tao Xin , Jalaj Arora
- 申请人地址： SE Sodertalje SE-151 85 US UT Salt Lake City 84108
- 专利权人： AstraZeneca AB,NPS PHARMACEUTICALS, INC.
- 当前专利权人： AstraZeneca AB,NPS PHARMACEUTICALS, INC.
- 当前专利权人地址： SE Sodertalje SE-151 85 US UT Salt Lake City 84108
- 国际申请： PCT/US05/04774 WO 20050215
- 主分类号： A61K31/4439
- IPC分类号： A61K31/4439 ; A61K31/4245 ; C07D413/14 ; C07D413/02
摘要：
The present invention relates to new compounds of formula (I), to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders.
信息查询
IPC分类:
